Related content

Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients

By                            

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3228-3232

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

By Kasimir-Bauer S.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 123-132

Springer Publishing Company

Access to resources Recommend Favorite

Detection of β-Subunit Human Chorionic Gonadotropin mRNA in the Peripheral Blood of Patients with Nonmetastatic Gestational Trophoblastic Disease

By Suzuka K.   Matsui H.   Iitsuka Y.   Sekiya S.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 53-56

Academic Press

Access to resources Recommend Favorite

Diagnosis of Minimal Residual Disease in Bone Marrow and Blood in Cancer Patients: Methods and Clinical Implications

By Kvalheim G.  

Acta Oncologica, Vol. 37, Iss. 5, 1998-10 ,pp. : 455-462

Informa Healthcare

Access to resources Recommend Favorite

Clinical Significance of Molecular Detection of Matrix metalloproteinase-1 in Bone Marrow and Peripheral Blood in Patients with Gastric Cancer

By Kosaka Yoshimasa   Mimori Koshi   Fukagawa Takeo   Ishikawa Kenji   Etoh Tsuyoshi   Katai Hitoshi   Sano Takeshi   Watanabe Masahiko   Sasako Mitsuru   Mori Masaki  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 430-437

Springer Publishing Company

Access to resources Recommend Favorite